India Glycols (BOM:500201) Cyclically Adjusted Revenue per Share: ₹581.08 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500201 India Glycols Ltd BOM:500201
66 GF Score
Price ₹1,072.35
GF Value ₹765.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is India Glycols Cyclically Adjusted Revenue per Share?

India Glycols BOM:500201 -1.13% 66 Cyclically Adjusted Revenue per Share is ₹581.08 as of Mar. 2026. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹765.57 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

India Glycols's adjusted revenue per share for the three months ended in Mar. 2026 was ₹153.285. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹581.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, India Glycols's average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-12), India Glycols's current stock price is ₹1072.35. India Glycols's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹581.08. India Glycols's Cyclically Adjusted PS Ratio of today is 1.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of India Glycols was 2.00. The lowest was 0.96. And the median was 1.64.


India Glycols  (BOM:500201) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

India Glycols's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1072.35/581.08
=1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of India Glycols was 2.00. The lowest was 0.96. And the median was 1.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


India Glycols Cyclically Adjusted Revenue per Share Related Terms


India Glycols Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for India Glycols's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

India Glycols Cyclically Adjusted Revenue per Share Chart

India Glycols Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 543.51 581.08

India Glycols Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 543.51 555.29 568.82 576.55 581.08

BOM:500201 vs DOW: Cyclically Adjusted Revenue per Share Comparison

For the Chemicals subindustry, India Glycols's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


India Glycols Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, India Glycols's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where India Glycols's Cyclically Adjusted PS Ratio falls into.


BOM:500201
66GF Score
India Glycols Ltd BOM:500201
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

India Glycols Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, India Glycols's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=153.285/164.2724*164.2724
=153.285

Current CPI (Mar. 2026) = 164.2724.

India Glycols Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 123.451 111.317 182.180
201809 153.609 115.142 219.153
201812 123.548 115.142 176.265
201903 130.193 118.202 180.937
201906 140.068 120.880 190.349
201909 137.177 123.175 182.946
201912 139.300 126.235 181.274
202003 14.342 124.705 18.893
202006 47.417 127.000 61.333
202009 90.556 130.118 114.326
202012 114.923 130.889 144.234
202103 110.383 131.771 137.610
202106 105.086 134.084 128.745
202109 125.976 135.847 152.336
202112 128.315 138.161 152.566
202203 94.863 138.822 112.255
202206 124.050 142.347 143.157
202209 102.031 144.661 115.863
202212 89.418 145.763 100.773
202303 59.215 146.865 66.234
202306 111.287 150.280 121.649
202309 125.024 151.492 135.571
202312 146.070 152.924 156.909
202403 145.468 153.035 156.150
202406 156.414 155.789 164.932
202409 155.270 157.882 161.554
202412 157.412 158.323 163.327
202503 139.420 157.552 145.367
202506 168.036 159.755 172.787
202509 176.437 162.289 178.593
202512 176.038 163.281 177.107
202603 153.285 164.272 153.285

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹581.08 mean?
India Glycols (BOM:500201) has a Cyclically Adjusted Revenue per Share of ₹581.08 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on India Glycols and its competitors.
Is India Glycols' Cyclically Adjusted Revenue per Share too high?
India Glycols' current Cyclically Adjusted Revenue per Share is ₹581.08. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Cyclically Adjusted Revenue per Share compare to DOW?
India Glycols' Cyclically Adjusted Revenue per Share of ₹581.08 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on India Glycols and its competitors. India Glycols's current Cyclically Adjusted Revenue per Share is ₹581.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹765.57, compared to a current price of ₹1,072.35 — trading 40.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹581.08. India Glycols' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Cyclically Adjusted Revenue per Share is ₹581.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is India Glycols (BOM:500201) Overvalued in 2026?

Based on GuruFocus' analysis, India Glycols stock appears to be overvalued. The current stock price of ₹1,072.35 is trading 40.1% above its estimated GF Value™ of ₹765.57. GuruFocus considers India Glycols to be Significantly Overvalued.

Key valuation signals for BOM:500201:

  • Cyclically Adjusted Revenue per Share: ₹581.08
  • GF Value™: ₹765.57 vs. price of ₹1,072.35 (40.1% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


India Glycols Business Description

Other Exchanges INDIAGLYCO:India
Address Plot No. 2B, Sector - 126, District Gautam Budh Nagar, Noida, UP, IND, 201304
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score

Get the complete analysis for BOM:500201

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,072.35
Price
₹765.57
GF Value